Physician profile
John L Bibb
NPI 1881733889
$713.06
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $22.59 · 2021: $18.60 · 2022: $33.67 · 2023: $25.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $149.90 | 2019 | |
| Eisai INC. | $109.96 | 2019 | |
| Merck Sharp & Dohme LLC | $66.50 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $44.52 | 2019 | |
| Lilly USA, LLC | $37.54 | 2019-2020 | |
| Pfizer INC. | $36.89 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $25.47 | 2023 | Epkinly, Imbruvica |
| Gilead Sciences, INC. | $25.14 | 2019 | |
| Puma Biotechnology, INC. | $20.85 | 2019 | |
| Abbvie INC. | $20.64 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.29 | 2019 | |
| Boston Scientific Corporation | $18.60 | 2021 | |
| Celgene Corporation | $17.38 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.62 | 2019 | |
| Sun Pharmaceutical Industries INC. | $16.29 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.81 | 2019 | |
| Dova Pharmaceuticals | $15.19 | 2019 | |
| Genentech USA, INC. | $11.69 | 2019 | |
| Sandoz INC. | $11.51 | 2019 | |
| Janssen Biotech, INC. | $11.21 | 2019 | |
| Advanced Accelerator Applications | $11.04 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bibb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.